@article{bd70fcb714a94a7a84385e5e7fde067f,
title = "Formation of the Australia and New Zealand Vasculitis Society to improve the care of patients with Vasculitis in Australian and New Zealand",
author = "Jessica Ryan and Joanna Tieu and Bhadran Bose and Ross Francis and Michael Gingold and Liang Goh and James Gray and Hill, \{Catherine L.\} and Pravin Hissaria and Sadia Jahan and Daman Langguth and Jennifer Li and Andrew McLean-Tooke and Peh, \{Chen A.\} and Mukhlesur Rahman and Tony Sammel and Stamp, \{Lisa K.\} and Mark Street and Sanjay Swaminathan and Wong, \{Nikki L.\} and Richard Kitching",
note = "Funding Information: There have been significant contributions from Australia and New Zealand in several international, multicentre investigator‐led clinical trials of AAV. These include PEXIVAS, by far the largest randomised trial to date in AAV, which included 704 patients of which 104 were from Australia and New Zealand. This was made possible with support from the Australasian Kidney Trials Network and National Health and Medical Research Council (NHMRC) funding. Other major AAV trials with significant Australia and New Zealand contributions include RITUXVAS, MYCYC, RITAZAREM and the industry‐led ADVOCATE study. Several of these trials have led to changes in clinical practice and substantial improvements in outcomes for patients with AAV. Close links with international groups such as the European Vasculitis Society, Vasculitis Clinical Research Consortium and research centres in Cambridge and Oxford provide optimism for future collaborative research. 15 16–18 Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = jul,
day = "1",
doi = "10.1111/imj.14898",
language = "English",
volume = "50",
pages = "781--783",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "7",
}